Thu, July 11, 2024

Jason McCarthy Upgraded (BCLI) to Strong Buy and Held Target at $30 on, Jul 11th, 2024

Jason McCarthy of Maxim Group, Upgraded "Brainstorm Cell Therapeutics Inc." (BCLI) to Strong Buy and Held Target at $30 on, Jul 11th, 2024.

Jason, nor any peers, have made any analyst calls on BCLI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30